Free Shipping on purchases over €100

Drasanvi Mineral Bisglicinato Hierro Ferrochel , 90 comprimidos

Drasanvi Mineral Bisglycinate Iron Ferrochel , 90 tablets

Ferrochel iron mineral bisglycinate iron, 90 tablets from Drasanvi is a gluten-free food supplement that helps to reduce tiredness and fatigue. Made from iron bisglycinate, it performs its function perfectly with hardly any side effects.

SKU: DR8436578541300
Sold out
16.25
€17.06
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Ferrochel iron mineral bisglycinate ferrochel, 90 tablets from Drasanvi is a gluten-free formula that helps to reduce fatigue. The food supplement also contributes to the maintenance of adequate iron levels.

It is developed with iron bisglycinate, which helps to reduce side effects such as irritation or constipation.

Iron is an essential mineral for the proper function of the body, and without an ideal amount in the body, profound fatigue can occur. For this reason, Drasanvi's supplement is a support product that helps to prevent this deficiency in the body.

Iron bisglycinate, the essential mineral in the supplement, is highly available and easily assimilated. Its level of absorption is regulated based on the iron content in the body. It is less toxic to the digestive system and contributes to the production of red blood cells, which facilitate the transport of oxygen in tissues and organs.

The food supplement is vegan, free from lupins, celery, peanuts, nuts, crustaceans, egg, milk, fish, mustard, molluscs, soya and sesame. It is therefore ideal for users with specific food intolerances.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.